Clinical Trials Sponsored by Medacta USA

Total 4868 results

MedPacto, Inc.

Completed

Dose Escalation and Proof-of-Concept Studies of Vactosertib (TEW-7197) Monotherapy in Patients With MDS

Myelodysplastic Syndromes

United States
MedPacto, Inc.

Active, not recruiting

TEW-7197 With Paclitaxel for the Treatment of Metastatic Gastric Cancer

Metastatic Gastric Cancer

Korea, Republic of
Motiva USA LLC

Recruiting

Long-Term Effectiveness of the Motiva Implants® Round and Round Ergonomix (MIRO)

Breast Augmentation

Australia, Costa Rica, Italy, Spain
Senju USA, Inc.

Completed

Evaluation of the Safety and Efficacy of Ketotifen 4.0% Patch as Compared to Placebo Patch, Olopatadine 0.2% Ophthalmic Solution, and Artificial Tears in the Conjunctival Allergen Challenge (CAC) Model of Acute Allergic Conjunctivitis

Allergic Conjunctivitis

United States
Teva Pharmaceuticals USA

Completed

Benazepril HCl 40 mg Tablets, Fed

Healthy

United States
Taro Pharmaceuticals USA

Completed

Adrenal Suppression and Pharmacokinetics of Topicort® Spray, 0.25% in Pediatric Patients With Plaque Psoriasis

Plaque Psoriasis

United States
Motiva USA LLC

Active, not recruiting

Study of the Safety and Effectiveness of Motiva Implants®

Breast Implants

United States, Germany, Sweden
Sironax USA, Inc.

Completed

A Pilot Study to Assess Safety and Efficacy of SIR1-365 in Patients With Severe COVID-19

Corona Virus Infection

Pakistan, United States, Mexico
AnGes USA, Inc.

Completed

Study of Hepatocyte Growth Factor (HGF) Via Plasmid Vector to Improve Perfusion in Critical Limb Ischemia Patients With Peripheral Ischemic Ulcers

Ischemia | Peripheral Vascular Disease | Arterial Occlusive Disease | Ulcers

United States
Taro Pharmaceuticals USA

Completed

A Study Comparing Adapalene Gel 0.1% and to Differin Gel in the Treatment of Acne Vulgaris

Acne Vulgaris

United States
Taro Pharmaceuticals USA

Completed

A Study Comparing Tretinoin Cream 0.025% and RETIN-A® Cream 0.025% in the Treatment of Acne Vulgaris

Acne Vulgaris

United States
AnGes USA, Inc.

Completed

A Phase IIB Pilot Study of a Modified Dosage Regimen of AMG0001 in Subjects With Critical Limb Ischemia

Vascular Diseases | Peripheral Arterial Disease | Critical Limb Ischemia

United States
Ribomic USA Inc

Completed

RBM-007 in Subjects witH ExudatIve Age-related Macular Degeneration (SUSHI)

Age-related Macular Degeneration

United States
Teva Pharmaceuticals USA

Completed

Zolpidem Tartrate 10 mg Tablets Under Non-Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Buspirone Hydrochloride 30mg Tablets, Fasting

Healthy

United States
Teva Pharmaceuticals USA

Completed

Buspirone Hydrochloride 30mg Tablets, Non-Fasting

Healthy

United States
Taro Pharmaceuticals USA

Completed

Bio-equivalence Study With Clinical Endpoints in the Treatment of Acne Vulgaris

Acne Vulgaris

United States
LDR Spine USA

Terminated

Multicenter Study of the Avenue L Interbody Spinal Fusion System Using VerteBRIDGE Plating and Posterior Fixation

Degenerative Disc Disease

United States
LDR Spine USA

Completed

Retrospective/Prospective Data Collection on the LDR ROIA Interbody Fusion Device With VerteBRIDGE Plating

Degenerative Disc Disease
LDR Spine USA

Completed

Retrospective/Prospective Data Collection on the LDR ROIC Interbody Fusion Device With VerteBRIDGE Plating

Degenerative Disc Disease

United States
GenesisCare USA
Dendreon

Completed

A Multicenter Trial Enrolling Men With Advanced Prostate Cancer Who Are to Receive Combination Radiation and Sipuleucel-T

Castrate Refractory Metastatic Prostate Cancer (mCRPC)

United States
Taro Pharmaceuticals USA

Completed

An Open Label, Safety Study to Assess the Potential for Adrenal Suppression.

Atopic Dermatitis

United States
Taro Pharmaceuticals USA

Completed

Study to Evaluate Efficacy and Safety of the Topical Product in Patients With Mild to Severe Scalp Psoriasis

Scalp Psoriasis
Taro Pharmaceuticals USA

Completed

A Randomized Double Blind Vehicle Controlled Dose Ranging Parallel Design Multiple Site Clinical Study

Plaque Psoriasis
Taro Pharmaceuticals USA

Completed

An Open Label, Safety Study to Assess the Potential for Adrenal Suppression

Plaque Psoriasis

United States
Taro Pharmaceuticals USA

Completed

Efficacy Study in Patients With Acne Vulgaris.

Acne Vulgaris
Taro Pharmaceuticals USA

Completed

Safety and Efficacy of NVXT Solution in Mild-to-Moderate Fungal Infection of the Toe Nail

Onychomycosis
Taro Pharmaceuticals USA

Completed

Evaluate Safety and Efficacy of Naftifine Hydrochloride Gel 2% and Naftin® Gel 2% in Tinea Pedis

Tinea Pedis
Taro Pharmaceuticals USA

Completed

To Evaluate the Therapeutic Equivalence and Safety of TRETINOIN CREAM, 0.05% and RLD in the Treatment of Acne Vulgaris

Acne Vulgaris

United States
MEDRx USA, Inc.

Completed

MRX-7EAT Etodolac-Lidocaine Topical Patch in the Treatment of Tendonitis and Bursitis of the Shoulder

Bursitis | Acute Tendonitis

United States
MEDRx USA, Inc.

Completed

Safety & Efficacy Study of MRX-7EAT Patch in the Treatment of Pain of the Shoulder

Shoulder Pain | Bursitis | Tendonitis

United States
LDR Spine USA

Completed

LDR Spine USA Mobi-C(R) Cervical Disc Prosthesis IDE

Degenerative Disc Disease

United States
Senju USA, Inc.

Completed

Safety and Efficacy Study of SUN 131 TDS as Compared to Placebo TDS in Adult Patients With a Chalazion

Chalazion

United States
Teva Pharmaceuticals USA

Completed

A Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled, Multicenter Study Comparing Diclofenac Sodium Gel, 3% to Solaraze® Gel, 3% in the Treatment of Actinic Keratosis on the Face or Bald Scalp

Actinic Keratosis

United States
Taro Pharmaceuticals USA

Completed

Study Comparing Clindamycin Phosphate and Benzoyl Peroxide Gel to Acanya® Gel and Both to a Vehicle Control in the Treatment of Acne Vulgaris

Acne Vulgaris
Taro Pharmaceuticals USA

Completed

Study Comparing Test to Aczone 5% and Both to a Placebo Control in the Treatment of Acne Vulgaris

Acne Vulgaris
Taro Pharmaceuticals USA

Completed

Study Comparing Adapalene/BP Gel to EPIDUO® FORTE and Both to a Placebo Control in Treatment of Acne Vulgaris

Acne Vulgaris
Taro Pharmaceuticals USA

Completed

Study Comparing Adapalene and Benzoyl Peroxide Gel 0.1%/2.5% to Epiduo® and Both to a Placebo Control in the Treatment of Acne Vulgaris

Acne Vulgaris
MetaCure (USA), Inc.

Completed

A Prospective, Clinical Trial of the TANTALUS® System in Treatment of Obese to Morbidly Obese Patients

Obesity | Type 2 Diabetes

United States
Teva Pharmaceuticals USA

Unknown

Clinical Equivalence of Azelastine Hydrochloride and Fluticasone Propionate, 137/50 mcg Nasal Spray to Dymista™

Seasonal Allergic Rhinitis

United States
Taro Pharmaceuticals USA

Completed

Safety and Tolerability of a Novel Malathion Formulation in Children Age 6-24 Months With Head Lice

Pediculosis

United States
Taro Pharmaceuticals USA

Completed

Effects of Desoximetasone Spray 0.25% in Patients With Moderate to Severe Plaque Psoriasis

Psoriasis

United States
Taro Pharmaceuticals USA

Completed

Bioequivalence Study of Two Imiquimod Cream 5%

Actinic Keratosis

United States
Taro Pharmaceuticals USA

Completed

Clinical Study to Evaluate the Bioequivalence of Two Imiquimod Cream 3.75% Formulations in Patients With Actinic Keratosis.

Actinic Keratosis
Taro Pharmaceuticals USA

Completed

A Study Comparing Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel to Duac® Topical Gel in the Treatment of Acne Vulgaris

Acne Vulgaris
Intercell USA, Inc.

Completed

Prevention, Randomized, Double-Blinded, Placebo-Controlled, Parallel Assignment, Safety/Efficacy Study

Traveler's Diarrhea

United States
Intercell USA, Inc.

Completed

Travelers' Diarrhea (TD) Vaccine Pivotal Efficacy Study

Travelers' Diarrhea

United Kingdom, Germany, Guatemala, Mexico
Teva Pharmaceuticals USA

Completed

Donepezil 10 mg Tablets Under Fed Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Donepezil 10 mg Tablets Under Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Norethindrone/Ethinyl Estradiol 0.4 mg/35 Mcg Chewable Tablets Under Non-Fasted Conditions

Healthy

United States

3

Subscribe